Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Bladder cancer is not a rare disease. It is one of the 10 most common cancers in the UK and the 5th most common cancer in the European Union.
Read Full NewsEven years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.
In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.
Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.
Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.
Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.
1.
Food insecurity linked to tumor growth in pediatric neuroblastoma
2.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
3.
Predicting adult mortality from oral cancer using a machine learning approach.
4.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
5.
Many patients learn they could have cancer in the emergency department
1.
Patient-Specific Tumor Resection Cavities With Biofabricated Reconstruction Materials
2.
Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment
3.
Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines
4.
The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition
5.
Pediatric Red-Cell Membrane Remodeling With Age: Mechanisms, Clinical Implications, and Management
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge